Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 437

1.

Gastrointestinal stromal tumors (GISTs) and second malignancies: A novel "sentinel tumor"? A monoinstitutional, STROBE-compliant observational analysis.

Rodriquenz MG, Rossi S, Ricci R, Martini M, Larocca M, Dipasquale A, Quirino M, Schinzari G, Basso M, D'Argento E, Strippoli A, Barone C, Cassano A.

Medicine (Baltimore). 2016 Sep;95(38):e4718. doi: 10.1097/MD.0000000000004718.

2.

Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score.

Zhu AX, Baron AD, Malfertheiner P, Kudo M, Kawazoe S, Pezet D, Weissinger F, Brandi G, Barone CA, Okusaka T, Wada Y, Park JO, Ryoo BY, Cho JY, Chung HC, Li CP, Yen CJ, Lee KD, Chang SC, Yang L, Abada PB, Chau I.

JAMA Oncol. 2016 Sep 22. doi: 10.1001/jamaoncol.2016.4115. [Epub ahead of print]

PMID:
27657674
3.

The Mental Health of Transgender Youth: Advances in Understanding.

Connolly MD, Zervos MJ, Barone CJ 2nd, Johnson CC, Joseph CL.

J Adolesc Health. 2016 Aug 17. pii: S1054-139X(16)30146-X. doi: 10.1016/j.jadohealth.2016.06.012. [Epub ahead of print] Review.

PMID:
27544457
4.

Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management.

Spritzer PM, Barone CR, de Oliveira FB.

Curr Pharm Des. 2016 Jul 20. [Epub ahead of print]

PMID:
27510481
5.

Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down's syndrome.

Romualdi D, Proto C, De Cicco S, Immediata V, Barone C, Romano C, Lanzone A.

Menopause. 2016 Jul 25. [Epub ahead of print]

PMID:
27465716
6.

An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation.

Iulita MF, Ower A, Barone C, Pentz R, Gubert P, Romano C, Cantarella RA, Elia F, Buono S, Recupero M, Romano C, Castellano S, Bosco P, Di Nuovo S, Drago F, Caraci F, Cuello AC.

Alzheimers Dement. 2016 Jul 21. pii: S1552-5260(16)30037-1. doi: 10.1016/j.jalz.2016.05.001. [Epub ahead of print]

PMID:
27452424
7.

A noise model for the evaluation of defect states in solar cells.

Landi G, Barone C, Mauro C, Neitzert HC, Pagano S.

Sci Rep. 2016 Jul 14;6:29685. doi: 10.1038/srep29685.

8.

LUX-Lung 7: is there enough data for a final conclusion?

Orlandi A, Calegari MA, Barone C.

Lancet Oncol. 2016 Jul;17(7):e267-8. doi: 10.1016/S1470-2045(16)30216-9. No abstract available.

PMID:
27396644
9.

Indications for prophylactic osteosynthesis associated with curettage in benign and low-grade malignant primitive bone tumors of the distal femur in adult patients: a case series.

Perisano C, Barone C, Stomeo D, Di Giacomo G, Vasso M, Schiavone Panni A, Maccauro G.

J Orthop Traumatol. 2016 Jul 9. [Epub ahead of print]

PMID:
27394916
10.

Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion.

Knauf F, Thomson RB, Heneghan JF, Jiang Z, Adebamiro A, Thomson CL, Barone C, Asplin JR, Egan ME, Alper SL, Aronson PS.

J Am Soc Nephrol. 2016 Jun 16. pii: ASN.2016030279. [Epub ahead of print]

PMID:
27313231
11.

Are TKIs favourable for the elderly with non-small-cell lung cancer?

Rossi S, D'Argento E, Schinzari G, Dadduzio V, Di Noia V, Cassano A, Barone C.

Oncotarget. 2016 May 17. doi: 10.18632/oncotarget.9389. [Epub ahead of print]

12.

Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab.

Basso M, Dadduzio V, Ardito F, Lombardi P, Strippoli A, Vellone M, Orlandi A, Rossi S, Cerchiaro E, Cassano A, Giuliante F, Barone C.

Medicine (Baltimore). 2016 May;95(20):e3722. doi: 10.1097/MD.0000000000003722.

13.

ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis.

Strippoli A, Rossi S, Martini M, Basso M, D'Argento E, Schinzari G, Barile R, Cassano A, Barone C.

Oncotarget. 2016 Jun 7;7(23):35159-68. doi: 10.18632/oncotarget.9063.

14.

Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations.

Pinto C, Barone CA, Girolomoni G, Russi EG, Merlano MC, Ferrari D, Maiello E.

Am J Clin Oncol. 2016 Aug;39(4):407-15. doi: 10.1097/COC.0000000000000291.

PMID:
27077276
15.

Killer-specific secretory (Ksp37) gene expression in subjects with Down's syndrome.

Salemi M, Barone C, Morale MC, Caniglia S, Romano C, Salluzzo MG, Rando RG, Ragalmuto A, Bosco P, Romano C.

Neurol Sci. 2016 May;37(5):793-5. doi: 10.1007/s10072-016-2554-5. Epub 2016 Mar 31.

PMID:
27032399
16.

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX.

Ciardiello F, Normanno N, Martinelli E, Troiani T, Pisconti S, Cardone C, Nappi A, Bordonaro AR, Rachiglio M, Lambiase M, Latiano TP, Modoni G, Cordio S, Giuliani F, Biglietto M, Montesarchio V, Barone C, Tonini G, Cinieri S, Febbraro A, Rizzi D, De Vita F, Orditura M, Colucci G, Maiello E; CAPRI-GOIM Investigators; CAPRI-GOIM investigators.

Ann Oncol. 2016 Jun;27(6):1055-61. doi: 10.1093/annonc/mdw136. Epub 2016 Mar 21.

PMID:
27002107
17.

Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.

Rossi S, Schinzari G, Basso M, Strippoli A, Dadduzio V, D'Argento E, Cassano A, Barone C.

Future Oncol. 2016 May;12(10):1299-307. doi: 10.2217/fon-2015-0065. Epub 2016 Mar 21.

PMID:
26996100
18.

Mice lacking myosin IXb, an inflammatory bowel disease susceptibility gene, have impaired intestinal barrier function and superficial ulceration in the ileum.

Hegan PS, Chandhoke SK, Barone C, Egan M, Bähler M, Mooseker MS.

Cytoskeleton (Hoboken). 2016 Apr;73(4):163-79. doi: 10.1002/cm.21292. Epub 2016 Apr 4.

PMID:
26972322
19.

A Rare Case of Esophageal Dysphagia in Children: Aberrant Right Subclavian Artery.

Barone C, Carucci NS, Romano C.

Case Rep Pediatr. 2016;2016:2539374. doi: 10.1155/2016/2539374. Epub 2016 Jan 20.

20.

Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling.

Bruscia EM, Zhang PX, Barone C, Scholte BJ, Homer R, Krause DS, Egan ME.

Am J Physiol Lung Cell Mol Physiol. 2016 Apr 15;310(8):L711-9. doi: 10.1152/ajplung.00284.2015. Epub 2016 Feb 5.

PMID:
26851259
Items per page

Supplemental Content

Loading ...
Write to the Help Desk